SCHEMBL8900441

SCHEMBL8900441

Brc1cccc(/C=C\c2cccc(Br)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.65
ALDH1A1 P00352 3/20 0.65
NFE2L2 Q16236 2/20 0.50
HSD11B1 P28845 1/20 0.50
SLC6A19 Q695T7 1/20 0.50
BACE1 P56817 1/20 0.50
CYP2D6 P10635 1/20 0.49
CYP1B1 Q16678 1/20 0.49
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CHRNA7 P36544 1/20 0.46
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699462 1.00 HSD17B3 (0.65) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL709614 1.00 HSD17B3 (0.65) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL699998 0.93 HSD17B3 (0.59) HSD17B3ALDH1A1NFE2L2BACE1MAPT
SCHEMBL699999 0.93 HSD17B3 (0.59) HSD17B3ALDH1A1NFE2L2BACE1MAPT
SCHEMBL8900696 0.91 HSD17B3 (0.57) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL699611 0.91 HSD17B3 (0.57) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL699610 0.91 HSD17B3 (0.57) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL11464066 0.90 HSD17B3 (0.61) HSD17B3ALDH1A1HSD11B1SLC6A19BACE1
SCHEMBL23935305 0.87 HSD17B3 (0.53) HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19
SCHEMBL7090618 0.87 ALDH1A1 (0.83) HSD17B3ALDH1A1HSD11B1SLC6A19BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663391-B1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls HOFFMANN LA ROCHE (CH) 1997-04-09 EP disclosed
US-5521160-A COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY HOFFMANN-LA ROCHE INC. (US) 1996-05-28 US disclosed
EP-0663391-A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed